Treatment Approaches for Patients With Oligodendrogliomas and Grade 2 Gliomas

Opinion
Video

Panelists discuss how they tailor treatment strategies for oligodendrogliomas and Grade 2 gliomas based on key clinical and molecular markers, with particular attention to insights from the CODEL trial and RTOG 9802 study.

  • How do you approach treatment decisions for patients with oligodendrogliomas and Grade 2 gliomas? What clinical and molecular factors most significantly influence your approach?
  • CODEL TRIAL
  • RTOG 9802
Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
9 Experts are featured in this series.
9 Experts are featured in this series.
2 experts are featured in this series.
9 Experts are featured in this series.
Related Content